Cetuximab (Erbitux) in Combination With Cisplatin or Carboplatin and 5-Fluorouracil in the First Line Treatment of Subjects With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (EXTREME)
|2||Active, not recruiting||
Cisplatin and 5-FU +/- Panitumumab for Patients With Nonresectable,Advanced or Metastatic Esophageal Squamous Cell Cancer
Efficacy and Safety of Cetuximab in Metastatic Penile Carcinoma (PENILANE)
† Study has passed its completion date and status has not been verified in more than two years.